New and Revised FDA Import Alerts for April 26
On April 26, 2012, the Food and Drug Administration posted new and revised versions of the following Import Alerts on the detention without physical examination of:
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
- 66-66: APIs That Appear To Be Misbranded Under 502(f)(1) Because They Do Not Meet The Requirements For The Labeling Exemptions In 21 CFR 201.122 (here)
- 66-41: Unapproved New Drugs Promoted In The U.S. (here)
- 66-40: Drugs From Firms Which Have Not Met Drug GMPs (here)
- 16-133: Tuna from Moon Fishery India Pvt Ltd (here)
- 16-81: Seafood Products Due to the Presence of Salmonella (here)